Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 7, 2009, Pages 1003-1013

  Saint Lu, N ^a   Tourdot, S ^a   Razafindratsita, A ^a,c   Mascarell, L ^a   Berjont, N ^a   Chabre, H ^a   Louise, A ^b   Van Overtvelt, L ^a   Moingeon, P ^a  

^a Stallergenes SA   (France)

^b INSTITUT PASTEUR   (France)

^c Parc Scientifique de Luminy   (France)

Author keywords

Allergy vaccines; Chitosan; Sublingual immunotherapy; Tolerance induction

Indexed keywords

ALLERGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CYTOKINE; GAMMA INTERFERON; GLUCOSAMINE; INTERLEUKIN 10; INTERLEUKIN 5; MUCOADHESIVE CHITOSAN MICROPARTICLE; OVALBUMIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BODY PLETHYSMOGRAPH; BRONCHITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL COUNT; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; SUBLINGUAL IMMUNOTHERAPY; TH2 CELL;

ADMINISTRATION, SUBLINGUAL; ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CHELATING AGENTS; CHITOSAN; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HYPERSENSITIVITY; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; LUNG; MICE; MICE, INBRED BALB C; MOUTH MUCOSA; OVALBUMIN; TH2 CELLS;

EID: 66749106297     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.01945.x     Document Type: Article

References (35)

1. Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006 61 : 20 23.
2. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
3. Dahl R, Kapp A, Colombo G, De Monchy JG, Rak S, Emminger W et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 118 : 434 440. (Pubitemid 44160721)
4. Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007 120 : 1338 1345. (Pubitemid 350225683)
5. Valenta R, Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002 14 : 718 727. (Pubitemid 35292418)
6. Linhart B, Valenta R. Molecular design of allergy vaccines. Curr Opin Immunol 2005 17 : 646 655. (Pubitemid 41506911)
7. Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007 120 : 278 285. (Pubitemid 47411528)
8. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006 61 : 151 165. (Pubitemid 43381824)
9. Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008 63 : 720 727.
10. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008 380 : 1404 1413.
11. O'Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003 2 : 727 735. (Pubitemid 37361788)
12. De Haar C, Kool M, Hassing I, Bol M, Lambrecht BN, Pieters R. Lung dendritic cells are stimulated by ultrafine particles and play a key role in particle adjuvant activity. J Allergy Clin Immunol 2008 121 : 1246 1254.
13. Neimert-Andersson T, Thunberg S, Swedin L, Wiedermann U, Jacobsson-Ekman G, Dahlén SE et al. Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. Allergy 2008 63 : 518 526.
14. Van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 2001 14 : 201 207. (Pubitemid 32884316)
15. Jayakumar R, Nwe N, Tokura S, Tamura H. Sulfated chitin and chitosan as novel biomaterials. Int J Bio Macromol 2007 40 : 175 181. (Pubitemid 46215727)
16. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo. Science 1990 250 : 1720 1723.
17. Mascarell L, Van Overtvelt L, Lombardi V, Razafindratsita A, Moussu H, Horiot S et al. A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route. Vaccine 2007 26 : 108 118. (Pubitemid 350213205)
18. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992 176 : 1693 1702.
19. Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H et al. Oral dendritic cells mediate antigen-specific tolerance by stimulating Th1 and regulatory CD4+ T cells. J Allergy Clin Immunol 2008 122 : 603 609.
20. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997 156 : 766 775. (Pubitemid 27396413)
21. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005 44 : 65 73. (Pubitemid 41111534)
22. Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2007 145 : 152 162.
23. Kumar M, Kong X, Behera AK, Hellermann GR, Lockey RF, Mohapatra SS. Chitosan IFN-gamma-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet Vaccines Ther 2003 1 : 3.
24. Chew JL, Wolfowicz CB, Mao HQ, Leong KW, Chua KY. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 2003 21 : 2720 2729. (Pubitemid 36703182)
25. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999 5 : 387 391. (Pubitemid 29180575)
26. Cunningham PT, Elliot CE, Holt PG, Thomas WR. Sublingual immunotherapy to inhalant allergen sensitisation and the effect of chitosan. World Allergy Congr 2007 Abstract 116.
27. Shibata Y, Foster LA, Bradfield JF, Myrvik QN. Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J Immunol 2000 164 : 1314 1321. (Pubitemid 30067244)
28. Strong P, Clark H, Reid K. Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin Exp Allergy 2002 32 : 1794 1800. (Pubitemid 35463868)
29. Ozdemir C, Yazi D, Aydogan M, Akkoc T, Bahceciler NN, Strong P et al. Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model. Clin Exp Allergy 2006 36 : 960 968. (Pubitemid 43972963)
30. Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL et al. Pathogen recognition and development of particulate vaccines: does size matter? Methods 2006 40 : 1 9. (Pubitemid 44415493)
31. Feng J, Zhao L, Yu Q. Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem Biophys Res Commun 2004 317 : 414 420. (Pubitemid 38452499)
32. Jilek S, Ulrich M, Merkle HP, Walter E. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm Res 2004 21 : 1240 1247. (Pubitemid 38954210)
33. Rafati H, Lavelle EC, Coombes AG, Stolnik S, Holland J, Davis SS. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Vaccine 1997 15 : 1888 1897. (Pubitemid 27504684)
34. Veronesi B, de Haar C, Lee L, Oortgiesen M. The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells. Toxicol Appl Pharmacol 2002 178 : 144 154. (Pubitemid 34214663)
35. Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 2007 4 : 73 84. (Pubitemid 46302130)